Cargando…
Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
BACKGROUND: Lipoprotein-associated phospholipase A2 (LpPLA2) levels are associated with stroke, though whether this extends to all populations and stroke subtypes is unknown. METHODS: Serum samples from stroke-free community participants in the Northern Manhattan Study were assayed for LpPLA2 mass a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886969/ https://www.ncbi.nlm.nih.gov/pubmed/24416164 http://dx.doi.org/10.1371/journal.pone.0083393 |
_version_ | 1782478945854160896 |
---|---|
author | Katan, Mira Moon, Yeseon P. Paik, Myunghee C. Wolfert, Robert L. Sacco, Ralph L. Elkind, Mitchell S. V. |
author_facet | Katan, Mira Moon, Yeseon P. Paik, Myunghee C. Wolfert, Robert L. Sacco, Ralph L. Elkind, Mitchell S. V. |
author_sort | Katan, Mira |
collection | PubMed |
description | BACKGROUND: Lipoprotein-associated phospholipase A2 (LpPLA2) levels are associated with stroke, though whether this extends to all populations and stroke subtypes is unknown. METHODS: Serum samples from stroke-free community participants in the Northern Manhattan Study were assayed for LpPLA2 mass and activity. Participants were followed annually for stroke. Cox-proportional-hazard models were fitted to estimate hazard-ratios and 95% confidence intervals (HR, 95% CI) for the association of LpPLA2 levels with ischemic stroke (IS), after adjusting for demographic and medical risk factors. RESULTS: Serum samples were available in 1946 participants, of whom 151 (7.8%) experienced a first IS during median follow-up 11 years. Mean age was 69 (SD 10), 35.6% were men, 20% non-Hispanic Whites, 22% non-Hispanic Blacks, and 55% Hispanics. LpPLA2 mass and activity levels were not associated with overall IS risk. LpPLA2 mass but not activity levels were associated with strokes due to large artery atherosclerosis (LAA; adjusted HR per SD 1.55, 95% CI 1.17–2.04). There was a dose-response relationship with LAA (compared to first quartile, 2nd quartile HR = 1.43, 95% CI 0.23–8.64; 3rd quartile HR = 4.47, 95% CI 0.93–21.54; 4th quartile HR = 5.07, 95% CI 1.07–24.06). The associations between LpPLA2-mass and LAA-stroke risk differed by race-ethnicity (p = 0.01); LpPLA2-mass was associated with increased risk of LAA among non-Hispanic Whites (adjusted HR per SD 1.44, 95% CI 0.98–2.11), but not other race-ethnic groups. CONCLUSION: LpPLA2-mass levels were associated with risk of atherosclerotic stroke among non-Hispanic White participants, but not in other race-ethnic groups in the cohort. Further study is needed to confirm these race-ethnic differences and the reasons for them. |
format | Online Article Text |
id | pubmed-3886969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38869692014-01-10 Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study Katan, Mira Moon, Yeseon P. Paik, Myunghee C. Wolfert, Robert L. Sacco, Ralph L. Elkind, Mitchell S. V. PLoS One Research Article BACKGROUND: Lipoprotein-associated phospholipase A2 (LpPLA2) levels are associated with stroke, though whether this extends to all populations and stroke subtypes is unknown. METHODS: Serum samples from stroke-free community participants in the Northern Manhattan Study were assayed for LpPLA2 mass and activity. Participants were followed annually for stroke. Cox-proportional-hazard models were fitted to estimate hazard-ratios and 95% confidence intervals (HR, 95% CI) for the association of LpPLA2 levels with ischemic stroke (IS), after adjusting for demographic and medical risk factors. RESULTS: Serum samples were available in 1946 participants, of whom 151 (7.8%) experienced a first IS during median follow-up 11 years. Mean age was 69 (SD 10), 35.6% were men, 20% non-Hispanic Whites, 22% non-Hispanic Blacks, and 55% Hispanics. LpPLA2 mass and activity levels were not associated with overall IS risk. LpPLA2 mass but not activity levels were associated with strokes due to large artery atherosclerosis (LAA; adjusted HR per SD 1.55, 95% CI 1.17–2.04). There was a dose-response relationship with LAA (compared to first quartile, 2nd quartile HR = 1.43, 95% CI 0.23–8.64; 3rd quartile HR = 4.47, 95% CI 0.93–21.54; 4th quartile HR = 5.07, 95% CI 1.07–24.06). The associations between LpPLA2-mass and LAA-stroke risk differed by race-ethnicity (p = 0.01); LpPLA2-mass was associated with increased risk of LAA among non-Hispanic Whites (adjusted HR per SD 1.44, 95% CI 0.98–2.11), but not other race-ethnic groups. CONCLUSION: LpPLA2-mass levels were associated with risk of atherosclerotic stroke among non-Hispanic White participants, but not in other race-ethnic groups in the cohort. Further study is needed to confirm these race-ethnic differences and the reasons for them. Public Library of Science 2014-01-09 /pmc/articles/PMC3886969/ /pubmed/24416164 http://dx.doi.org/10.1371/journal.pone.0083393 Text en © 2014 Katan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Katan, Mira Moon, Yeseon P. Paik, Myunghee C. Wolfert, Robert L. Sacco, Ralph L. Elkind, Mitchell S. V. Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study |
title | Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study |
title_full | Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study |
title_fullStr | Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study |
title_full_unstemmed | Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study |
title_short | Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study |
title_sort | lipoprotein-associated phospholipase a2 is associated with atherosclerotic stroke risk: the northern manhattan study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886969/ https://www.ncbi.nlm.nih.gov/pubmed/24416164 http://dx.doi.org/10.1371/journal.pone.0083393 |
work_keys_str_mv | AT katanmira lipoproteinassociatedphospholipasea2isassociatedwithatheroscleroticstrokeriskthenorthernmanhattanstudy AT moonyeseonp lipoproteinassociatedphospholipasea2isassociatedwithatheroscleroticstrokeriskthenorthernmanhattanstudy AT paikmyungheec lipoproteinassociatedphospholipasea2isassociatedwithatheroscleroticstrokeriskthenorthernmanhattanstudy AT wolfertrobertl lipoproteinassociatedphospholipasea2isassociatedwithatheroscleroticstrokeriskthenorthernmanhattanstudy AT saccoralphl lipoproteinassociatedphospholipasea2isassociatedwithatheroscleroticstrokeriskthenorthernmanhattanstudy AT elkindmitchellsv lipoproteinassociatedphospholipasea2isassociatedwithatheroscleroticstrokeriskthenorthernmanhattanstudy |